Carregant...
Regression of Subependymal Giant Cell Astrocytoma With Rapamycin in Tuberous Sclerosis Complex
The authors present a 21-year-old woman who has been receiving rapamycin for 5 months for bilateral subependymal giant cell astrocytomas. The patient was started at a dose of 0.2 mg/kg/day. Levels were maintained between 11 and 13 ng/mL. Magnetic resonance imaging of the brain 2½ months after initia...
Guardat en:
Autors principals: | , , |
---|---|
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
2008
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3072698/ https://ncbi.nlm.nih.gov/pubmed/18952591 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0883073808321764 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|